Colorectal cancer (advanced) - irinotecan, oxaliplatin and raltitrexed

  • Technology appraisal guidance
  • TA93
  • Published: 

This guidance has been updated and replaced by NICE guideline NG151.

The recommendations on raltitrexed have been withdrawn because its use is established clinical practice.